Clinical Trial

Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility

Study acronym: DI-MOB
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In contrast to the trend expected based on existing prediction models, dengue incidence was historically low during the pandemic mobility restrictions of 2020-2021 in most dengue endemic countries. This highlights that current transmission models do not correctly take human mobility into account. Within a pilot-study in Cienfuegos, South-Central Cuba, we will characterise the epidemiological spread and distribution of dengue outbreaks (2012-2025) in districts repeatedly involved in previous dengue outbreaks as initiating, case-concentrating or transmission sustaining areas. This will be linked with fine-grained mobility data and socio-spatial characterizations of commuting flows and population hubs where people are concentrated during day-time (time when transmission happens). This information, together with entomological and environmental risk-data, will be used to i) improve the accuracy of mathematical dengue models, ii) better understand the transmission process and iii) inform and improve the design of disease control strategies. The project will contribute to much-needed evidence-based guidance for public health actors on improved prevention strategies of epidemics dispersion and where and when to implement control measures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-12.
Status change: Recruiting → Active, Not Recruiting 2026-04-17
Trial Details
NCT Number NCT06599970
Lead Sponsor Institute of Tropical Medicine, Belgium
Collaborators: Cienfuegos Provincial Ministry of Health, Cuba, University Ghent, Institute Pedro Kouri, Ministry of Public Health (Cuba)
Conditions Dengue, Arbovirus Infections, Epidemic Disease, Behavior, Health
Enrollment 810 participants
Start Date 2024-06-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-22